Published date: 22 December 2017
Closed opportunity - This means that the contract is currently closed. The buying department may be considering suppliers that have already applied, or no suitable offers were made.
Contract summary
Industry
General management consultancy services - 79411000
Evaluation consultancy services - 79419000
Location of contract
London
Value of contract
£130,000
Procurement reference
17_10_03
Published date
22 December 2017
Closing date
12 January 2018
Contract start date
2 March 2018
Contract end date
31 March 2018
Contract type
Service contract
Procedure type
Competitive quotation (below threshold)
The buyer selects a group of potential suppliers to invite to tender.
This procedure can be used for procurements below the relevant contract value threshold.
Contract is suitable for SMEs?
Yes
Contract is suitable for VCSEs?
No
Description
The Blood and Infection Programme of Care is seeking support for it Immunoglobulin Improving Value Project.
Immunoglobulin is commissioned by NHS England in line with Department of Health Clinical guidelines for immunoglobulin use.
https://www.gov.uk/government/publications/clinical-guidelines-for-immunoglobulin-use-second-edition-update
The guidelines state which conditions immunoglobulin is recommended for and these are colour coded according to priority. A red classification indicates the highest priority as there could be a risk to life without treatment. A blue classification is for those indications where there is some evidence of benefit but for which there may be alternative treatments and for which treatment may be modified in times of supply shortages of immunoglobulin. Grey indications are those for which the evidence is weak, including rare disorders.
It is envisaged that the successful organisation will be able to provide the required clinical evidence reviews to meet our objectives of providing safe, effective, evidence based care and will have the relevant experience, knowledge and capability to carry out detailed clinical evidence reviews for the grey indications from the Clinical Guidelines for Immunoglobulin Use 2nd edition.
It is expected the chosen provider will be able to carry out the following:
Scoping reviews to identify literature reporting on the use of immunoglobulin, in people with a grey indication. It would include a scoping of the literature to:
1. Identifying the research question (PICO)
2. Identifying relevant studies (search)
3. Study selection
4. Charting data
5. Collating, summarising and reporting results, interpretation and conclusions
Then provide rapid reviews for those indications where there are experimental controlled trials or observational studies with a control group including:
1. Assessing quality of included literature
2. Measures of treatment effect
3. Summarising and interpreting results
Please note that that this contract may be extended for an additional 3 months.
Interested parties must be registered on Bravo Solutions in order to access the ITT documents. Please use the following address if you are not already registered: https://nhsengland.bravosolution.co.uk/web/login.html.
IN ADDITION, PLEASE ENSURE YOU EMAIL VANESSA.AMISSAH@NHS.NET TO EXPRESS AN INTEREST BY FRIDAY 12TH JANUARY 2018, 12 NOON, AT THE LATEST. IT IS ENVISAGED THAT THE INVITATION TO TENDER DOCUMENTS WILL BE MADE AVAILABLE BY MID-LATE JANUARY 2018.
About the buyer
Contact name
Vanessa Amissah
Address
5th Floor Stephenson House
London
NW1 2PL
England
Share this notice
Closing: 12 January 2018
All content is available under the
